GCM
GOSS icon

Graham Capital Management’s Gossamer Bio GOSS Stock Holding History

Graham Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-456
Closed -$113K – 1309
2025
Q4 		$113K Sell
456
-386
-46% -$88.1K ﹤0.01% 1129
2025
Q3 		$177K Buy
842
+256
+44% +$45.1K ﹤0.01% 1085
2025
Q2 		$57.7K Buy
586
+224
+62% +$19.5K ﹤0.01% 1238
2025
Q1 		$31.9K Sell
362
-75
-17% -$6.94K ﹤0.01% 1244
2024
Q4 		$31.6K Buy
+437
New +$30K ﹤0.01% 1196
2024
Q3 		– Sell
-131
Closed -$9.45K – 1186
2024
Q2 		$9.45K Sell
131
-108
-45% -$6.46K ﹤0.01% 1002
2024
Q1 		$22.6K Buy
+239
New +$21K ﹤0.01% 1025
2022
Q4 		– Sell
-1,883
Closed -$1.8M – 1142
2022
Q3 		$1.8M Buy
+1,883
New +$1.87M 0.07% 258

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Graham Capital Management's GOSS Position: Q1 2026 in Review

Graham Capital Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 456 shares — an estimated $113K sold.

Graham Capital Management first reported a position in GOSS in Q3 2022 and held it in 8 quarters. The position peaked at $1.8M in Q3 2022. 181 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Graham Capital Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 456 Gossamer Bio shares in Q1 2026, an estimated $113K.
  • Graham Capital Management first reported a position in Gossamer Bio in Q3 2022 and held it in 8 quarters.
  • Graham Capital Management's Gossamer Bio position peaked at $1.8M in Q3 2022.
  • 181 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.